Related Experiment Video
Updated: May 7, 2026
08:21
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
2.0K
Applied pharmacogenomics in cardiovascular medicine
1Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee; email: peter.e.weeke@vanderbilt.edu , dan.roden@vanderbilt.edu.
Annual Review of Medicine
|October 12, 2013
Summary
Genetic variations significantly impact how individuals respond to medications, affecting drug efficacy and toxicity. Pharmacogenomics offers personalized cardiovascular treatments by analyzing these genetic differences.
Area of Science:
- Pharmacogenomics
- Cardiovascular Medicine
- Drug Metabolism
Background:
- Individual responses to drug therapies exhibit significant heterogeneity.
- Genetic variations in drug elimination or target pathways are key contributors to variable drug efficacy and toxicity.
- Decades of research have established links between genetic factors and drug responses.
Purpose of the Study:
- To review methods for accumulating and validating pharmacogenomic findings.
- To highlight the implementation of pharmacogenomics in clinical practice.
- To discuss the role of pharmacogenomics in cardiovascular medicine.
Main Methods:
- Review of existing studies on interindividual drug response.
- Analysis of genetic variants in drug metabolism and target pathways.
- Examination of pharmacogenomic associations in cardiovascular conditions.
Main Results:
- Pharmacogenomic associations are crucial in cardiovascular medicine, including clopidogrel for in-stent thrombosis, warfarin dosing, simvastatin-induced myotoxicity, and drug-induced arrhythmias.
- Validated genetic findings are increasingly being integrated into clinical decision-making.
- Methods for accumulating and validating pharmacogenomic data have been established.
Conclusions:
- Pharmacogenomics is essential for optimizing drug therapy and minimizing adverse events in cardiovascular medicine.
- Implementing pharmacogenomic approaches can lead to more personalized and effective patient care.
- Continued research and validation are necessary for broader clinical adoption.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
01:29Pharmacogenetics and Pharmacogenomics: Overview
264
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
264
01:27Pharmacogenetics of Drug Metabolism: Overview
196
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
196
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
01:27Principles of Pharmacogenetics: Types of Genetic Variants
143
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
143
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84